drugset / Trial / NCT05378074
Hypersensitivity to Opening of BKCa Channels in Post-Traumatic Headache
RandomizedCrossoverQuadruple-blindBasic science
Summary
The aim is to investigate whether opening of large conductance calcium-activated potassium (BKCa) channels induces headache with migraine-like features in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).
Timeline
- Start
- 2022-09-01
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
Outcome
Met primary endpoint
paper 11 (52%) of 21 participants after MaxiPost infusion, in contrast to four (19%) participants following placebo (P = .02). PMID 38890563 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FLINDOKALNER | Small molecule | 0.05 mg | Intravenous |